MYGN Projected Dividend Yield
Myriad Genetics, Inc. ( NASDAQ : MYGN )Myriad Genetics, Inc. is a genetic testing and precision medicine company. Co. develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. Co. is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. 21 YEAR PERFORMANCE RESULTS |
MYGN Dividend History Detail MYGN Dividend News MYGN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |